BlackRock, Inc. 13D and 13G filings for Fulgent Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-03 4:17 pm Sale | 2025-03-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 1,819,823 5.900% | -1,942,055 (-51.62%) | Filing |
| 2024-01-23 4:13 pm Purchase | 2023-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,761,878 12.700% | 234,096 (+6.64%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,527,782 12.000% | 0 (Unchanged) | Filing |
| 2023-01-20 3:00 pm Purchase | 2022-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,527,782 12.000% | 106,531 (+3.11%) | Filing |
| 2022-01-27 5:14 pm Unchanged | 2021-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,421,251 11.500% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,421,251 11.500% | 363,936 (+11.90%) | Filing |
| 2021-07-12 08:29 am Purchase | 2021-06-30 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,057,315 10.500% | 1,072,448 (+54.03%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 1,984,867 8.200% | 1,984,867 (New Position) | Filing |